Table 4 Competing risk analysis of recurrence (N=51)
From: Survival analysis of extramammary Paget’s disease (EMPD) in a tertiary hospital in Taiwan
Variate | Recurrence rate | Sub-HR | 95% CI | p-value |
|---|---|---|---|---|
Gender | ||||
Female (N=12) | 16.67% | Reference | Reference | Reference |
Male (N=39) | 15.38% | 0.884 | 0.178–4.381 | 0.8799 |
Age | ||||
Age less than 75 years old (N=25) | 20.00% | Reference | Reference | Reference |
Age= 75 years old or more (N=26) | 11.54% | 0.673 | 0.161–2.818 | 0.5878 |
Lesion site | ||||
Genital region or other (N=36) | 16.67% | Reference | Reference | Reference |
Perianal or perineal (N=15) | 13.33% | 0.835 | 0.169–4.138 | 0.8253 |
Size of lesion | ||||
Lesion = 2 cm or less (N=16) | 6.25% | Reference | Reference | Reference |
Lesion lager than 2 cm (N=35) | 20.00% | 3.743 | 0.460–30.454 | 0.2171 |
Invasion of dermis | ||||
No dermal invasion (N=45) | 11.11% | Reference | Reference | Reference |
Deep dermal invasion (N=6) | 50.00% | 7.863 | 1.848–33.449 | 0.0052 |
Metastasis | ||||
Without metastasis (N=44) | 9.09% | Reference | Reference | Reference |
With any metastasis (N=7) | 57.14% | 9.103 | 2.249–36.849 | 0.0020 |
Concurrent malignancy | ||||
No concurrent malignancy (N=32) | 12.50% | Reference | Reference | Reference |
Adnexal or Internal malignancy (N=19) | 21.05% | 1.955 | 0.488–7.828 | 0.3436 |
Excision margin status (N=47) | ||||
Margin not free (N=18) | 22.22% | Reference | Reference | Reference |
Margin free (N=29) | 13.79% | 0.575 | 0.144–2.300 | 0.4338 |
Intraepithelial lesion (N= 31) | ||||
Margin not free (N=8) | 25.00% | Reference | Reference | Reference |
Margin free (N=23) | 13.04% | 0.463 | 0.077–2.779 | 0.3998 |